Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir Switch for Liver Fat in HIV+
NCT03374358Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jan 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Helsinki University Hospital. Started Jan 2018; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03374358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03374358.